Why Is Penumbra (PEN) Down 10.6% Since Last Earnings Report?

Core Viewpoint - Penumbra's shares have declined approximately 10.6% since the last earnings report, underperforming the S&P 500, raising questions about the potential for a breakout or continued negative trend leading up to the next earnings release [1] Estimates Movement - Fresh estimates for Penumbra have trended downward over the past month, indicating a negative shift in expectations [2] VGM Scores - Penumbra currently holds a strong Growth Score of A, a Momentum Score of B, and a Value Score of D, placing it in the bottom 40% for the value investment strategy. The aggregate VGM Score for the stock is B, which is relevant for investors not focused on a single strategy [3] Outlook - The overall trend of estimates for Penumbra has been downward, with a Zacks Rank of 3 (Hold), suggesting an expectation of in-line returns in the coming months [4] Industry Performance - Penumbra is part of the Zacks Medical - Instruments industry. Intuitive Surgical, a peer in the same industry, has seen a 6.8% gain over the past month, reporting revenues of $2.25 billion for the last quarter, reflecting a year-over-year increase of 19.2% [5] - For the current quarter, Intuitive Surgical is projected to report earnings of $1.93 per share, representing an 8.4% increase from the previous year, with a Zacks Consensus Estimate showing a 1% decrease over the last 30 days [6]